-
China grants approval for homegrown COVID-19 pills
2023-01-29
China has recently granted conditional approval to two homegrown COVID-19 oral pills, the National Medical Products Administration said on Sunday.
-
Nation's new COVID cases, deaths down significantly
2023-01-28
COVID-19 infections are on a sharp downtrend nationwide after cases peaked around Dec 22, when the number of new cases was around 7 million per day, and the number of deaths in hospitals has also declined significantly, the Chinese Center for Disease Control and Prevention said on Wednesday.
-
Second China domestic ECMO products approved for marketing
2023-01-17
On January 17, 2023, the Extracorporeal Membrane Oxygenation auxiliary device of RocketMedical Co., Ltd. (Rocket Medical) is approved with conditions through emergency review by China NMPA.
-
Patient monitor approved for marketing
2023-01-06
Recently, the innovative product "patient monitor" of Shenzhen Comen Medical Instruments Co., Ltd. is approved for marketing by China NMPA.
-
China Domestic ECMO products approved for marketing
2023-01-05
On January 4, 2023, the Extracorporeal Membrane Oxygenation System Console and its matching disposable kit of Chinabridge (Shenzhen) Medical Technology Co., Ltd. are approved through emergency review by China NMPA, to ensure the treatment needs of patients with severe cases of COVID-19 infection according to the demands of epidemic prevention and control.
-
China updates COVID-19 diagnosis, treatment protocol
2023-01-10
Introducing a set of revisions, health authorities on Friday released the 10th edition of the country's COVID-19 treatment plan, which guides hospitals nationwide as Omicron-fueled outbreaks keep progression across the nation.
